ADCT R&D to Revenue
Adc Therapeutics Sa · R&D to Revenue
ADCT R&D to Revenue
Latest reported90.22%period ending
ADCT Quarterly R&D/Revenue (9621.28% → 90.22%)
Latest values, visible window
High-resolution chart · PNG
ADCT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 90.2224% | |
| 99.2213% | |
| 78.862% | |
| 163.1643% | |
| 159.7219% | |
| 125.5937% | |
| 160.2661% | |
| 176.029% | |
| 139.5462% | |
| 142.5525% | |
| 180.6432% | |
| 196.2327% | |
| 162.5369% | |
| 202.0588% | |
| 69.8201% | |
| 54.6062% | |
| 280.7067% | |
| 105.2776% | |
| 249.806% | |
| 279.9498% | |
| 1,051.4096% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1,109.0724% | |
| 1,990.2564% | |
| 11,297.0874% | |
| 11,297.0874% | |
| 9,621.28% | |
| 9,621.28% |